Goldman Sachs Makes Positive Comments on CVS (CVS) Ahead of Results
Goldman Sachs Makes Positive Comments on CVS (CVS) Ahead of Results
StreetInsider.com - 23 minutes ago
Goldman Sachs issued positive comments today on CVS Caremark Corporation (NYSE: CVS) ahead of earnings due on Nov 5, reiterating their Conviction Buy List rating and $40 price target. The firm ...
- 11 reads
- Feed: CVS Pharmacy News
- Original article
